section name header

Evidence summaries

Glucocorticoids for Acute Laryngotracheitis in Children

Glucocorticoids reduce symptoms of croup, shorten hospital stay, and reduce the rate of return visits in children. Level of evidence: "A"

Summary

A Cochrane review [Abstract] 1 included 45 studies with a total of 5 888 children aged up to 18 years. Twenty-six studies investigated any glucocorticoid comparedt to placebo. Of these, 15 investigated dexamethasone,4 investigated budesonide, 3 prednisolone, 1 fluticasone, and 3 both dexamethasone and budesonide. Four studies investigatedany glucocorticoid compared to epinephrine, and 13 studies investigated one glucocorticoid comparedto another glucocorticoid.

Compared to placebo, glucocorticoids improved symptoms of croup at 2 hours (SMD -0.65, 95% CI -1.13 to -0.18; statistical heterogeneity I²=81%; 7 studies, n=426), and the effect lasted for at least 24 hours (SMD -0.86, 95% CI -1.40 to -0.31; statistical heterogeneity I²=81%; 8 studies, n=351). Fewer return visits and/or (re)admissions occurred in patients treated with glucocorticoids (RR 0.52, 95% CI 0.36 to 0.75; statistical heterogeneity I²=52% 10 studies, n=1 679), and glucocorticoids reduced the length of stay in hospital by about 15 hours (MD -14.90, 95% CI -23.58 to -6.22; statistical heterogeneity I²=54% 8 studies, n=476). Serious adverse events were infrequent.

Dexamethasone seemed to reduce the return visits or (re)admissions for croup by almost half (RR 0.55, 95% CI 0.28 to 1.11; statistical heterogeneity I²=59%; 4 studies, n=1 537) compared to prednisolone, although the difference was not statistically significant, and showed a 28% reduction in the use of supplemental glucocorticoids as an additional treatment (RR 0.72, 95% CI 0.53 to 0.97; 2 studies, n=926).

Compared to 0.15 mg/kg, 0.60 mg/kg dexamethasone reduced the severity of croup at 24-hour (SMD 0.63, 95% CI 0.16 to 1.10; 1 study, n=72), but not at 2 hours (SMD 0.27, 95% CI 0.76 to 0.22; statistical heterogeneity I²=62%; 2 studies, n=861), at 6 hours (SMD 0.45, 95% CI 1.26 to 0.35; statistical heterogeneity I²=85%; 3 studies, n=178), and at 12 hours (SMD 0.60, 95% CI 4.39 to 3.19; statistical heterogeneity I²=98%; 2 studies, n=113). There was no difference between doses of dexamethasone in return visits or (re)admissions of children or both (RR 0.91, 95% CI 0.71 to 1.17; 3 studies, n=949) or length of stay in the hospital or emergency department (MD 0.12, 95% CI 0.32 to 0.56; 2 studies, n=892). The need for additional treatments, such as epinephrine, intubation or use of supplemental glucocorticoids did not differ between doses of dexamethasone.

The following decision support rules contain links to this evidence summary:

    References

    • Aregbesola A, Tam CM, Kothari A, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev 2023;1(1):CD001955 [PubMed]

Primary/Secondary Keywords